Ankit Mahadevia Insider Trading for July 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ankit Mahadevia.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Ankit Mahadevia for July 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Option Exercise | M | 5.90 | 1,600 | 9,440 | 118,888 | |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Option Exercise | M | 5.90 | 3,076 | 18,148 | 120,488 | |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.92 | 200 | 3,584 | 65,817 | 66 K to 65.8 K (-0.30 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.90 | 200 | 3,580 | 66,017 | 66.2 K to 66 K (-0.30 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.71 | 100 | 1,771 | 66,217 | 66.3 K to 66.2 K (-0.15 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.62 | 100 | 1,762 | 66,317 | 66.4 K to 66.3 K (-0.15 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.58 | 400 | 7,032 | 66,417 | 66.8 K to 66.4 K (-0.60 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.55 | 100 | 1,755 | 66,817 | 66.9 K to 66.8 K (-0.15 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.50 | 500 | 8,750 | 66,917 | 67.4 K to 66.9 K (-0.74 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Buy | M | 5.90 | 1,600 | 9,440 | 67,417 | 65.8 K to 67.4 K (+2.43 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.62 | 3,076 | 54,204 | 65,817 | 68.9 K to 65.8 K (-4.46 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Buy | M | 5.90 | 3,076 | 18,148 | 68,893 | 65.8 K to 68.9 K (+4.67 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Option Exercise | M | 5.90 | 1,600 | 9,440 | 118,888 | |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Option Exercise | M | 5.90 | 3,076 | 18,148 | 120,488 | |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.92 | 200 | 3,584 | 65,817 | 66 K to 65.8 K (-0.30 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.90 | 200 | 3,580 | 66,017 | 66.2 K to 66 K (-0.30 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.71 | 100 | 1,771 | 66,217 | 66.3 K to 66.2 K (-0.15 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.62 | 100 | 1,762 | 66,317 | 66.4 K to 66.3 K (-0.15 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.58 | 400 | 7,032 | 66,417 | 66.8 K to 66.4 K (-0.60 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.55 | 100 | 1,755 | 66,817 | 66.9 K to 66.8 K (-0.15 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.50 | 500 | 8,750 | 66,917 | 67.4 K to 66.9 K (-0.74 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Buy | M | 5.90 | 1,600 | 9,440 | 67,417 | 65.8 K to 67.4 K (+2.43 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.62 | 3,076 | 54,204 | 65,817 | 68.9 K to 65.8 K (-4.46 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Buy | M | 5.90 | 3,076 | 18,148 | 68,893 | 65.8 K to 68.9 K (+4.67 %) |